Drugs / Meningococcal ACWY Polysaccharide Vaccine
last change Jul 2010 re-read 2 minutes ago

Meningococcal ACWY Polysaccharide Vaccine

also known as MPSV4
Developed for
meningococcal meningitis

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00474487 Comparator May → Aug 2007 meningococcal meningitis Novartis Vaccines Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Meningococcal ACWY Polysaccharide Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00474487
Known as MPSV4 “This study compared the investigational quadrivalent meningococcal CRM₁₉₇ conjugate vaccine, MenACWY-CRM, with licensed quadrivalent polysaccharide (MPSV4) and conjugate...” PMID 20655261 Jul 2010
Route Subcutaneous “administered by subcutaneous injection” NCT00474487